Member Info for TWatcher

12th of march £90M antibody contracts were posted, of which Ciga are getting £6.6M. @£5.15 a test, thats around 1.3M tests, of which ODX will get 25%, say 320K tests.

CIGA. £2.8M & £3.8M total £6.6M
https://bidstats.uk/tenders/2021/W10/746651662
https://bidstats.uk/tenders/2021/W10/746651706

Abbot £62M
https://bidstats.uk/tenders/2021/W10/746651670

Una health £13M
https://bidstats.uk/tenders/2021/W10/746651666

SD biosensor £9M
https://bidstats.uk/tenders/2021/W10/746651706

it shone thru, must go with the name.

A few days ago I posted links to a range of antibody lft bidstat entries that appeared12th march, but were not previously discussed here. Here's the details again.

CIGA. £2.8M & £3.8M total £6.6M
given the often reposting of bidstat contracts, unsure if these are 2 separate contract, or one replaces the other.
https://bidstats.uk/tenders/2021/W10/746651662
https://bidstats.uk/tenders/2021/W10/746651706

Abbot £62M
https://bidstats.uk/tenders/2021/W10/746651670

Una health £13M
https://bidstats.uk/tenders/2021/W10/746651666

SD biosensor £9M
https://bidstats.uk/tenders/2021/W10/746651706

Assuming ciga are 2 separate deals, that's £6.6M combined. Given abingdon revealed recently they were getting £5.15 per ABC test, then on that basis that's 1.28M tests. Abingdon's guaranteed 50%, or 640K test. ODX will get 25%, 320K tests...or less than 1/2 weeks output based on the 1.2M capacity forecast for end of March. Mind you it's more than their previous order which was 250K units.

The other 3 suppliers are getting orders for just over 16M tests, on a fair assumption they are being paid the same as abingdon.

I think you meant futility :)

Checked the thread...nope not one person posting about ODX, that's kinda sad for those posters, such an obsessive lot, best to keep discussions on topic i.e. about ODX.

the only UK validated test available for manufacture is Surescreens. Given that all reports on here for tests seen are reporting Innova, either surescreen hasn't actually starting supplying yet, or they haven't gotten to the end users yet.

hey...another title with my name in it !

tsales there was no notion of loan equipment from uk gov when that graph was posted, never mind discussions with the government. This is the same gov that issued a 75M contract for antibody tests with the RTC, but only order 1M tests for a total of £5.2M, and used a clause in the contract to do so.

The sad thing is, just about everyone here who has been in ODX for months and months knows there is no association between that graph and the antigen contract, however if someone wants to run with that narrative, then they appear to be happy to stay quiet if it means some newbies are drawn into a story that does not exist.

load of crap. the graph was produced 6 months ago, long before any notion of gov antigen test, at a time when antibody test was going to be a thing, and the company assumed a mass vaccination program would involve a mass antibody testing program.

Just shows how easy it is to retrospectively make facts fit the story you want to portray.

Specifically citing that the test is done at home and read at home. Positive test followed up with a PCR.

Also interesting figure in same article that in 2 days in the week just passed, 1.8M tests occurred.

https://www.bbc.co.uk/news/uk-56551832

Not suggesting that TT will not happen, however the fact is, it's still on-going. Without completion difficult to see how they can be made in production volumes.

Appears I'm the only one that noticed that the tweet confirms that the Mologic TT is STILL ongoing.

"the technology transfer will conclude in due course"

Speculating, which is all we can do given the lack of detail, either all 3 batches have not yet been done (they previously told us that TT including doing 3 batches) or Mologic has put the brakes on and not signed off that the 3 batches conform to the requirements, even though ODX is confident that they do.

All we know for sure is that it is not concluded as of today.

blueskipper12. good to see you are learning to do longer posts. I had assumed you were giving me your gratitude as from your posting history it seems your function here is to post "thank you".

for LFTs.
antibody = finger blood
antigen = nose/throat swab
both give results in 15-30 mins. Neither *needs* to be sent away as there is a visual indication like a pregnancy test. However for various reasons at the moment most of these need to be assessed by a "professional", be that a nurse or other type person. Helps to ensure the test was performed correctly, and read correctly.

Some people really don't like when some facts are presented to them. That's 4 posts calling me out by name, people that took the energy to type nothing but diatribe, and yet did they argue against the points made...nope...strange that. Apparently one even hears voices when he reads this stuff.

Particularly chuffed to get a reply from Blueskipper12. He used more words that he usually does in his posts. Of his 48 posts in total, none contain any comment, information, opinion or unique thought.

Now back, to, you know, ODX. the CEO made no reference to when production will commence, nor to ANY historic production. That is factually correct, whether you like it or not and stands in stark contrast with odx twitter stating as fact last month "In April we will deliver 2M LFTs a week"....which begins next thursday.

It is also factually correct he failed to mention 1 of only 3 covid LFT tests that ODX can make when assessing how capacity might be utilised. Its not like its a long list.

I noted three things from the interview.

1)he said:- " Any CEO of a manufacturing business will tell you that what matters are not future customer estimates but real purchase orders"

That is what I've been saying here literally for months, so its surprising that when he says it, he doesn't see the irony in the fact that ODX has not announced a single covid LFT order beyond the 250K units.

2)When asked about the worst case scenario, he calls out by name all the other ODX LFT tests that can use the capacity. It is glaring that the visitect antibody is left out. Confirmation of something I've highlighted here on several occasions, that the visitect antibody test is a dead duck. ODX decision making on test selection seems consistently poor. Elisa test, no one wanted it, Visitect test, no one wants its. RTC test, no one wants it in volume.

Mologic test ?, yet to be seen whether this is the transformative test for them, it entirely depends on whether this is actually the test that gov selected.

3) No talk about when they will manufacture product. Or how much they have manufactured since Oct. Not a single indication that production is underway in any significant way. April starts next Thursday. ODX tweeted in Feb "In april we will deliver 2M LFTs a week". No such statement of delivery in this interview.

on another thread I posted that recent bidstat entries in March indicate contracts for approx £90M for antibody LFTs, of which CIGA are listed as getting between £3M-£6.6M (unclear if the two entries are separate or one supercedes the other). Ciga are an RTC member. Assuming the Ciga entries are for RTC tests, thats 600K-1250K RTC tests, of which odx will get 25% (you can bet the other partners will take up their full allocation as they are doing little else). So thats 150K-312K tests, or less than 1/2 a week's ODX capacity, which is to be 1.2M tests a week by end of March.

Here's a copy of that post.

Perhaps I missed it being previously discussed, but I see Ciga mentioned in 2 bidstat awards in march.

https://bidstats.uk/tenders/2021/W10/746651706
https://bidstats.uk/tenders/2021/W10/746651662

Ciga is a member of the antibody RTC. The Ciga website does not mention that they represent any other providers of antibody LFT, so its possible that these relate to RTC tests. Given the inconsistency with bidstat entries, you can't be sure if these are two separate tenders or one replaces the other, they were both published on the same day. One for £2.8M, one for £3.8M.

On the same date, Abbot got a contract for £62.M antibody LFTs, UNA health got 13M and SD biosensor got £9M.

So thats around £90M antibody LFT's announced mid-March, of which Ciga got between £3-£6.6M

by the 16th of Feb, the message was changed from "capacity of approximately 2 million tests per week by the end of April"

To
"This April, we'll deliver 2m rapid LFTs a week."
https://twitter.com/OmegaDiagnostic/status/1361662415281278978?s=20

The exact same phrase was used the following day on another tweet
https://twitter.com/OmegaDiagnostic/status/1362040022015348738?s=20

Talking about capacity is one thing. The more recent tweets could not be clearer, in April they'll deliver 2M tests a week. thats delivering 8M lfts in April. Nothing stated about what happens after April

That £32M is a distribution contract, sending tests and PPE to schools on a next day service.

Key requirements of the contract include:

• Pick boxes of tests and guidance in accordance with the varying orders received from DHSC ready for dispatch

• Pick PPE and pack into boxes in accordance with the varying orders received from DHSC ready for dispatch• Deliver boxes of tests, guidance and PPE in varying quantities to the 32,000 sites during school hours• Next day delivery of test, guidance and PPE may also be required in emergency cases• Manage inventory levels and place orders with DHSC to ensure enough stock to meet demand• Inbound and store pallets of stock to support the ongoing demand• Record the batch information of boxes of tests dispatched to ensure product traceability

yeah...the one that says don't beleive me !